Home Tags Zinc

Tag: zinc

First-Patient Dosed with BRY812 in Phase I Trial

ADC Review | Editorial Team
A first patient has been dosed in a Phase I Clinical trial of BRY812, a third-generation antibody-drug conjugate (ADC) targeting LIV-1 being developed by BioRay Pharmaceutical Co., for the treatment of advanced malignant tumors.